ADVERTISER PLATFORMS

Musk Puts the Twitter Takeover On Hold

Twitter | May 17, 2022

Twitter
Elon Musk, the richest man in the world, has put a halt on his acquisition of Twitter due to recent announcements from the company about the prevalence of spam and bot accounts on the platform. Nearly two weeks ago, Twitter released a report which stated that fake accounts on the platform made up less than 5 percent of daily users. The information lacked rigidity to support the claims, and it seemed flexible in its assessment, which became a turn-off for Musk. On this premise, Musk tweeted,

"Twitter deal temporarily on hold pending details supporting calculation that spam/fake accounts do indeed represent less than 5% of users"

 
Twitter also hinted at taking this report with a pinch of salt, as it stated,

"The actual number of false or spam accounts could be higher than we have estimated. We are continually seeking to improve our ability to estimate the total number of spam accounts"

Musk claims himself as a "free speech absolutist and offered $44billion to takeover twitter on April 25th. Musk's purchase was expected to lead to a renewed focus on personal verification and a crackdown on bot accounts. To verify a user's identity on Twitter, Tesla CEO Elon Musk wants them to go through a more rigorous process than simply providing an email or phone number. This would prevent the prevalence of spambots on the platform, and the authorities will be able to act on the violators of the speech laws.

Twitter's stock was initially down more than 20% in pre-market trade following the announcement, but the stock regained slightly. In his second tweet, Musk stated that he is "still committed to acquisition" two hours after his first one.

Spotlight

Words can be powerful, but pictures pack a punch. They convey a world of meaning with a quick glance and make complex content understandable and scannable. In fact, research has shown that 90% of the information transmitted to the brain is visual. Infographics provide these visual vehicles in the form of graphic design to both simplify and clarify more complicated content.

Spotlight

Words can be powerful, but pictures pack a punch. They convey a world of meaning with a quick glance and make complex content understandable and scannable. In fact, research has shown that 90% of the information transmitted to the brain is visual. Infographics provide these visual vehicles in the form of graphic design to both simplify and clarify more complicated content.

Related News

MOBILE ADVERTISING

Adverty and InMobi Introduce In-Game Ads for Global Brands and Agencies

Adverty, InMobi | April 28, 2021

Adverty AB, the world's leading in-game platform for advertisers, agencies, and game developers, and InMobi, the world's leading independent marketing cloud, announced today the official launch of in-game ads on InMobi Exchange. Using Adverty's multi-patented in-game ad technology, brands and agencies around the world will be able to target premium mobile users with advertisements that blend into the game environment, such as electronic advertisement boards in an e-sports arena or the increasingly common casual and hypercasual gaming space.'' "This news shows that the most exciting, largely unexplored media frontier is still very much open for business. Furthermore, both branding and performance advertisement options are available, allowing advertisers to target previously unreachable audiences at scale and turbocharge their marketing campaigns in new ways. With this collaboration, the path is clear for future innovation " says Tobias Knutsson, CEO of Adverty. Kunal Nagpal, SVP and GM, Publisher Platforms and Exchange at InMobi, said: "One of these new frontiers is in-game ads, which allows advertisers to interact with their customers in a highly intuitive manner. InMobi's technology and unparalleled mobile in-app expertise allow global advertisers to reach a highly engaged and diverse mobile gaming audience in an increasingly relevant medium." Indeed, in recent years, gaming has emerged as an incredibly appealing media channel for advertisers, with prospects for brands to deliver high-impact creatives to a highly engaged global audience of over 3 billion gamers. In terms of both users and time spent, mobile gaming experienced exponential growth in 2020. Through its revolutionary technology designed specifically for gaming, Adverty provides unobtrusive advertisement that links brands and audiences, while buy-side clients can now access new formats in mobile games at scale more conveniently than ever before. Adverty introduced a world-first In-MenuTM format earlier this year to complement its In-PlayTM offerings, in response to high demand for its seamless and non-interruptive in-game inventory. This enables contextually appropriate IAB display banner advertising to be displayed in-game and complements a highly advanced product suite that also allows brands to take over billboards and other virtual outdoor locations within games. About Adverty Adverty, the leading in-game platform, uses innovative display advertisement technology designed specifically for games to deliver seamless advertising that connects brands and people. The platform provides true in-game ad inventory at scale and enables content creators to commercialize the whole experience through unobtrusive, easy-to-integrate, interactive advertising. Adverty, which was established in 2016, has offices in Stockholm, London, New York, Madrid, Helsinki, St Petersburg, and Lviv collaborates with advertisers, agencies, and developers to unlock audiences and gaming revenue streams. About InMobi InMobi creates genuine connections between brands and consumers by leveraging its technology platforms and unparalleled access to mobile intelligence. Its Marketing Cloud opens up new avenues for brands to understand, identify, engage, and acquire connected consumers. InMobi, a leading technology firm, has been named to the 2018 and 2019 CNBC Disruptor 50 lists, as well as one of Fast Company's 2018 World's Most Innovative Companies.

Read More

AD NETWORKS

Google Introduces ‘Multisearch’ in Lens

Google | April 11, 2022

Google has recently introduced a new feature, 'Multisearch,' to aid their visual search function Google lens. The multisearch feature will enable a user to refine their visual search queries. With multisearch, the users can combine their graphic and text parameters to get elaborated search results. Google, in its blog, has given a use case to consider where a user can take a screenshot of their shopping-related search query and add a question to find variants of the item searched. E.g., suppose a user searched apparel that appeared in Orange colour in the search result; then it can use the google lens to find the green variant of that apparel (as shown in the blog image). Although this feature currently aims to assist in shopping-related queries, its possibilities seem to be endless. Sometimes users experience a lack of proper keywords to search their query. However, visuals+text search query capabilities will resolve this inconvenience. E.g., one can use Google lens to scan their plant and explore how to care for it by typing the query. Visual search criteria may play a significantly larger role in the future, when augmented reality glasses and other visual technologies become available. As consumers become more acclimated to visual references and visual capture via their glasses, the ability to include those same aspects into search may become a far more significant discovery feature. Currently, this feature is in the beta phase and can only be used in the US region. Google gives credit to recent development in AI tech; it says in their blog, "All this is made possible by our latest advancements in artificial intelligence, which is making it easier to understand the world around you in more natural and intuitive ways. We're also exploring ways in which this feature might be enhanced by MUM– our latest AI model in Search– to improve results for all the questions you could imagine asking."

Read More

DISPLAY ADVERTISING

National Advertising Division Refers Advertising for PLx Pharma's Vazalore to FTC After Compliance Review

National Advertising Division | December 23, 2021

The National Advertising Division (NAD) of BBB National Programs has referred advertising claims made by PLx Pharma, Inc. to the Federal Trade Commission (FTC) for review and possible enforcement action after the company declined to accept NAD's recommendations to modify certain claims for its Vazalore immediate-release aspirin product. In Case #6912, NAD recommended, among other things, that PLx Pharma: Modify the claim "Vazalore has up to 5X greater absorption than enteric coated aspirin" to avoid conveying the message that the claimed difference in absorption related to superior clinical efficacy and disclose that the reported results were limited to diabetic, obese subjects. Discontinue the claim "The Miracles of Aspirin Fully Realized." Discontinue the claim "Better gastrointestinal safety" (or modify it to convey the limited message that Vazalore causes fewer erosions and ulcers in the first week of treatment than traditional immediate release aspirin). In PLx Pharma's advertiser's statement it agreed to comply with NAD's recommendations and incorporate them in updates to its company website and development of Vazalore's marketing campaign. Thereafter, the challenger, Bayer Healthcare LLC, asked NAD to open a compliance inquiry based on concerns about advertising on PLx Pharma's website directed to healthcare professionals (HCP) and a television commercial. In a compliance matter, NAD must determine whether the advertiser has made a bona fide, good-faith effort to comply with NAD's recommendations. Although NAD determined that some new advertising claims were not appropriate for review in a compliance matter because they were not previously reviewed by NAD or were monadic performance claims, a few others were substantially similar to claims challenged in the underlying proceeding. Therefore, NAD considered whether these new claims fully comply with NAD's recommendations. Television Commercial Regarding PLx Pharma's television commercial, NAD determined that, in context, the claim "Aspirin Made Amazing" was substantially similar to the claim NAD recommended be discontinued in the underlying challenge, "The Miracles of Aspirin Fully Realized." NAD noted that both phrases reasonably convey the unsupported message that Vazalore provides superior cardiovascular benefits or gastrointestinal safety. Therefore, NAD recommended that Vazalore modify its commercial to avoid conveying this message. Consistent with the underlying decision, NAD noted that nothing precludes PLx Pharma from: Making a properly limited claim based on the clinical study results that the Vazalore 325 mg aspirin causes fewer erosions and ulcers in the first week of treatment than traditional immediate release aspirin or from touting that it provides a new delivery system; or Using the "Aspirin Made Amazing" tagline to highlight truthful attributes that make Vazalore different from other products provided, however, the context does not overstate its performance benefits. Advertising Directed to Healthcare Professionals NAD noted that it appreciates PLx Pharma's efforts to create a gated site for HCPs separate from its consumer-facing website. In the underlying decision, NAD recommended that the advertiser modify the claim "Vazalore has up to 5x greater absorption than enteric coated aspirin" to avoid conveying the message that the claimed difference in absorption related to superior clinical efficacy and disclose that the reported results were from a limited study population, diabetic, obese subjects. In the compliance inquiry, NAD considered whether the advertiser's disclosure of the limitations of its clinical study, as referenced on its HCP-facing website, namely the title of the study, its characteristics including the study's population, and finally the results, complied with this recommendation. NAD determined that it did not and, therefore, recommended that the disclosure concerning the 5x absorption claim clearly and conspicuously reference the limited population of the clinical study. Further, NAD determined that claims on PLx Pharma's "Features and Benefits" page convey a comparative safety message as to competing traditional release aspirin. Consequently, NAD recommended that the advertiser modify this advertising to make clear the limitations of its study (i.e., that Vazalore causes fewer erosions and ulcers in the first week of treatment than traditional immediate release aspirin). While the advertiser made modifications following the original challenge, they have declined to make additional modifications as NAD requested. As a result, NAD is referring this matter to the appropriate government agencies for review and possible law enforcement action. All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. About BBB National Programs: BBB National Programs is where businesses turn to enhance consumer trust and consumers are heard. The non-profit organization creates a fairer playing field for businesses and a better experience for consumers through the development and delivery of effective third-party accountability and dispute resolution programs. Embracing its role as an independent organization since the restructuring of the Council of Better Business Bureaus in June 2019, BBB National Programs today oversees more than a dozen leading national industry self-regulation programs, and continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-directed marketing, and privacy. To learn more, visit bbbprograms.org. About the National Advertising Division: The National Advertising Division (NAD) of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and leveling the playing field for business.

Read More